![]() ![]() ![]() |
| L-Carnitine L-Tartrate Inhibits Gestational Diabetes | |
|
|
VitaNet ® Staff | 01/24/06 |

Date:
January 24, 2006 05:15 PM
Author: VitaNet ® Staff
(support@vitanet.net)
Subject: L-Carnitine L-Tartrate Inhibits Gestational Diabetes
Vienna, Austria—Intake of L-carnitine L-tartrate during pregnancy may thwart a sequence of reactions leading to gestational diabetes, according to a study published in Chemical Monthly (136, 8:1523-1533), 2005) (www.springerlink.com).
Scientists from the University of Vienna noted deficiency of carnitine in pregnant women from the 12th week of gestation through delivery leads to down-regulation of expression of certain enzymes involved in fatty acid metabolism; loMRNA levels of these enzymes promotes an increase in free fatty acid levels conducive to insulin resistance. The researchers found supplementation with L-carnitine L-tartrate (as L-Carnipure, from Lonza) increased relative mRNA levels of these enzymes in pregnant women.
In a release on the findings, Lonza (www.lonza.com) noted there appears to be increasing evidence that L-carnitine may play an important role during pregnancy, particularly in women following a meat-reduced or vegetarian diet.
Disclaimer: All material provided in the VitaNet ®, LLC. website is provided for educational purposes only. Consult your physician regarding the applicability of any information provided in the VitaNet ®, LLC. website to your symptoms or medical condition. *These statements have not been evaluated by the Food and Drug Administration. These web pages are not intended to diagnose, treat, cure, or prevent any disease.